PMC8915120_01
PMC8915120_02
(A) Clinical history of the patient from 1994 to the end of the case study. *Therapeutic plan is slightly modified due to the patient's complaints of insomnia. #One of the antipsychotics used is discontinued due to the appearance of hyperprolactinemia. After stabilizing a hypomanic episode, olanzapine (oral) is substituted by aripiprazole (LAI), and therapy is readjusted to control insomnia. (B) Pharmacotherapy doses. Daily doses administered through the different stages of the patient clinical evolution. Mg, milligram; D, day.
fpsyt-12-830608-g0001.jpg
PMC8915120_02_fpsyt-12-830608-g0001.jpg
F1
For pharmacogenetic interactions (see Figure 1B).
PMC8915120_03
PMC8915120_04
PMC8915120_05
PMC8915120_06
PMC8915120_07
PMC8915120_08
PMC8915120_09